Huachuang Securities: Maintains a "strong recommendation" rating on Guoshengtang (02273.HK) with a target price of HK$41.5.

According to the Wisdom Financial APP, Huachuang Securities released a research report stating that, based on the 2025 annual report and the latest operating conditions of Gu Sheng Tang (02273.HK), the company's forecasted net profit attributable to shareholders for 2026-2028 is 425 million, 513 million, and 593 million yuan respectively, with year-on-year increases of 20.6%, 20.7%, and 15.6%. The current stock price corresponds to PEs of 13, 11, and 9 for 2026-2028 respectively. With reference to comparable medical service companies, the company is given a target PE of 20 for 2026, corresponding to a target stock price of 41.5 Hong Kong dollars. The "strong buy" rating is maintained.